bpc 157 spinal cord injury Peptide therapy with pentadecapeptide in traumatic nerve Stable Gastric Pentadecapeptide BPC 157

Research shows that BPC-157 Peptide Nasal Spray may support new blood vessel formation, called angiogenesis

No adverse effects were reported, but rigorous, large-scale trials are lacking

Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB)

BPC-157 demonstrates a bell-shaped dose-response curve in several models, meaning too high a dose may reduce therapeutic effects. Sikiric, P

TB-500 is a synthetic peptide designed to mimic aspects of Thymosin Beta-4 activity, functioning through actin regulation, promoting cell migration and anti-inflammatory responses